The prognostic value of modified Glasgow Prognostic Score in pancreatic cancer: a meta-analysis

• Main Authors: Huan Zhang, Dianyun Ren, Xin Jin, Heshui Wu
• Format: Article
• Language: English
• Published: BMC 2020-09-01
• Series: Cancer Cell International
• Subjects: Pancreatic cancer; Modified Glasgow Prognostic Score (mGPS); Prognostic value; Meta-analysis
• Online Access: http://link.springer.com/article/10.1186/s12935-020-01558-4

Abstract Background Several studies were conducted to explore the prognostic value of modified Glasgow Prognostic Score (mGPS) in pancreatic cancer, which reported contradictory results. The purpose of this meta-analysis was to summarize and further investigate the correlation between mGPS and overall survival (OS) in pancreatic cancer. Methods A systematic literature search was performed in PubMed, EMBASE, ISI Web of Science, Cochrane library databases and OVID to identify eligible studies published from Jan 1, 2011 to June 20, 2020. Pooled hazard ratios (HRs) with corresponding 95% confidence intervals (CIs) were used to detect the prognostic significance of mGPS in patients with pancreatic cancer. Results A total of 222 non-repetitive studies were identified, and 20 related studies that explored the association between survival outcomes and mGPS in pancreatic cancer patients were finally enrolled in this meta-analysis. The results showed a significant correlation between high level of mGPS and poor OS (HR = 1.50, 95% CI 1.20–1.89, P < 0.0001). Similar results were observed in the subgroup analyses based on the treatment regimen and research region. Conclusions Our study suggested the close association between poor prognosis and high level of mGPS, which will be helpful for future clinical applications in patients with pancreatic cancer.